TBXU ETF

TBXU ETF
$37.67
Do a full portfolio x-ray with TBXU
Just $25 once·$69/mo·Download sample
Get mine for $25

Fund Essentials - as of Jun 30, 2026

Net Assets
$3M
Expense Ratio
0.98%
Dividend Yield (Current)
1.82%
Holdings
10
Inception Date
Oct 1, 2025
Fund Family
Direxion Shares ETF Trust
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Quarterly

Performance

YTD+11.53%

Asset Allocation

Stocks: 23.41%
Bonds: 2.74%
Cash: 13.63%
Other: 60.23%
Do a full portfolio x-ray with TBXU
$25 once. No subscription. Download sample.
Get mine for $25

Top Holdings

View All →
TickerNameWeight
-Dx D Biotech T 5 Bull 2X Etf Swap102.19%
-Dx D Biotech T 5 Bull 2X Etf Swap41.83%
FTIXXGoldman Finl Sq Trsry Inst 50630.85%
REGNRegeneron Pharmaceuticals, Inc.11.57%
VRTXNvaesrtex Pharmaceuticals Inc11.46%
Top 10 Concentration: 239.14%Report Date: Jun 30, 2026
Download all 10 holdings for TBXU
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
1.82%
Frequency
Quarterly
Latest Distribution
$0.11
Jun 23, 2026
12M Distributions
4 payments
Total: $0.62

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This ETF
PRO
Peer Avg
PRO

TBXU ETF Overview

TBXU ETF (Direxion Daily Biotech Top 5 Bull 2X ETF) is managed by Direxion Shares ETF Trust with $2.9M in net assets. TBXU expense ratio is 0.98%, holding 10 positions across sectors including Health Care, Financials. Inception date: 2025-10-01.

TBXU performance shows a YTD return of 11.53%.. TBXU dividend yield stands at 1.82%, paid quarterly.

TBXU top holdings include Dx D Biotech T 5 Bull 2X Etf Swap (102.2%), Dx D Biotech T 5 Bull 2X Etf Swap (41.8%), Goldman Finl Sq Trsry Inst 506 (30.9%), Regeneron Pharmaceuticals, Inc. (11.6%), Nvaesrtex Pharmaceuticals Inc (11.5%). Go to all TBXU holdings, TBXU sectors, or TBXU dividends.

TBXU can be compared against other funds. Use TBXU overlap to find shared positions, or TBXU vs another fund for a side-by-side view. TBXU alternatives are available via the screener, along with tax-loss harvesting opportunities.

1 Month
+6.60%
YTD
+11.53%
1 Year
N/A
3 Year
N/A

Top 10 Holdings (net long exposure of 207% (≈2x))

#TickerNameSectorWeight
1-Dx D Biotech T 5 Bull 2X Etf SwapOther102.19%
2-Dx D Biotech T 5 Bull 2X Etf SwapOther41.83%
3FTIXXGoldman Finl Sq Trsry Inst 506Unknown30.85%
4REGNRegeneron Pharmaceuticals, Inc.Health Care11.57%
5VRTXNvaesrtex Pharmaceuticals IncHealth Care11.46%
6AMGNAmgen Inc.Health Care11.30%
7GILDGilead SciencesHealth Care11.06%
8ARGX:ASArgenx Se Sponsored Adr (1 Ads : 1 Ordinary)Health Care10.58%
9-Goldman Sachs Fin Gov 465 Institut X9UsdgldsOther6.55%
10DGCXXDreyfus Govt Cash Man InsFinancials1.75%